Provided by Tiger Trade Technology Pte. Ltd.

BOAN BIOTECH

4.310
+0.0100.23%
Volume:3.70M
Turnover:15.71M
Market Cap:2.68B
PE:27.05
High:4.365
Open:4.300
Low:4.175
Close:4.300
52wk High:16.520
52wk Low:4.110
Shares:622.00M
HK Float Shares:622.33M
Volume Ratio:0.80
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.159
ROE:0.33%
ROA:0.59%
PB:0.84
PE(LYR):27.05
PS:2.93

Loading ...

BOAN BIOTECH Shares Surge on Share Buyback Plan and New Drug Approval in Macau

Stock News
·
May 19

Boan Biotechnology Announces HK$200 Million Share Buyback

MT Newswires Live
·
May 14

Boan Biotech Announces Plan for On-Market Share Repurchase of up to HK$200 Million

Bulletin Express
·
May 13

Shandong Boan Biotechnology launches share buyback program worth up to HK$ 200 million

Reuters
·
May 13

Shandong Boan Biotechnology Co Ltd - to Repurchase Shares up to HK$200 Mln

THOMSON REUTERS
·
May 13

Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026

Bulletin Express
·
May 07

BOAN BIOTECH's Stock Plummets Nearly 70% in Eight Months, Faces Critical Test to Maintain Stock Connect Eligibility

Stock News
·
May 01

博安生物营收破7.848亿元净利同比下滑 资本与研发投入助力长期增长

Bulletin Express
·
Apr 29

Boan Biotech’s 2025 ESG Report: Quad-ISO Certification, 50 Patents Granted and 13,468 tCO₂e Emissions

Bulletin Express
·
Apr 29

Shandong Boan Biotech publishes 2025 annual report

Reuters
·
Apr 29

Boan Biotech Announces Proposed Adoption of Restricted Share Unit Incentive Scheme for H Shares

Bulletin Express
·
Apr 28

BOAN BIOTECH Proposes Restricted Share Unit Incentive Scheme

Stock News
·
Apr 28

Shandong Boan Bio proposes H-share restricted share unit incentive scheme

Reuters
·
Apr 28

BOAN BIOTECH Secures CDE Approval to Launch Phase II Trial of BA1106 + BA1104 for Driver-Gene-Negative NSCLC

Bulletin Express
·
Apr 26

BOAN BIOTECH Receives CDE Acceptance for Phase II Trial Application of BA1106 Combined with BA1104 in Non-Small Cell Lung Cancer

Stock News
·
Apr 26

Shandong Boan says China CDE accepts Phase II trial application for BA1106-BA1104 combo in NSCLC

Reuters
·
Apr 26

Boan Biotech’s March Filing Shows Stable Share Base and Sufficient Public Float

Bulletin Express
·
Apr 08

BRIEF-Shandong Boan Biotechnology Says Dou Changlin Resigned As Executive Director

Reuters
·
Apr 01

BOAN BIOTECH Announces Executive Reshuffle and Strategic Committee Changes

Stock News
·
Mar 31

Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026

Bulletin Express
·
Mar 31